Vertaling van "screening study-1 breast cancer mortality " (Frans → Nederlands) :

20. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up.
19. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up.

49. Miller Ab TTBCJWC. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up.
50. Miller Ab TTBCJWC. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up.

43. Olsen A, Njor HS, Vejborg I, Schwartz W, Dalgaard P, Jensen M-B, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study.
44. Olsen A, Njor HS, Vejborg I, Schwartz W, Dalgaard P, Jensen M-B, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study.

Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L, et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.
Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. preventive services task force.

56. Van Dijck JA, Verbeek AL, Beex LV, Hendriks JH, Holland R, Mravunac M, et al. Breast-cancer mortality in a non-randomized trial on mammographic screening in women over age 65.
57. Van Dijck JA, Verbeek AL, Beex LV, Hendriks JH, Holland R, Mravunac M, et al. Breast-cancer mortality in a non-randomized trial on mammographic screening in women over age 65.

Table 9: Evidence form systematic reviews and meta analysis (breast cancer mortality reduction in intervention group) Study ID Ref Population Intervention Results of meta-analysis Comments Level of evidence
Table 7: Evidence form systematic reviews and meta analysis (breast cancer mortality reduction in intervention group) Study ID Ref Population Intervention Results of meta-analysis Comments Level of evidence

12. Baxter N. Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer?
11. Baxter N. Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer?

myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European prospective Investigation into Cancer and nutrition study (EPIC-Heidelberg).
with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European prospective Investigation into Cancer and nutrition study (EPIC-Heidelberg).

Application Presentation: Symposium A web-based Support System for the belgian Breast Cancer Screening Program (.Powerpoint) by Eddy Husson, Informatique Médicale et Biostatistique, Université de Liège (B)
Application Presentation: A web-based Support System for the belgian Breast Cancer Screening Program(.Powerpoint) by Eddy Husson, Informatique Médicale et Biostatistique, Université de Liège (B)

Le programme suit les recommandations du «European Guidelines for quality assurance in breast cancer screening and diagnosis ».
Het programma is in overeenstemming met de aanbevelingen van de “European Guidelines for quality assurance in breast cancer screening and diagnosis”.